Charles Hosemann, MD
Orthopaedic Surgery · Flowood, MSNPI 1114136751
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by ALON Medical Technology at 59.4% of the total. Reporting peaked in 2019 at $4,652 and has fallen 96.9% since, to $145 in 2025.
Across 108 payments — averaging $70.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$5K
- Arthrex$2K
- Amgen$362
- Smith+Nephew$137
- Zimmer Biomet$112
- Pacira Pharmaceuticals Incorporated$106
- plus $485 from 16 others
What the payments were for
- Travel & lodging$2,21429%
- Food & beverage$1,91725%
- Education$3,51546%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 12 | $4,539 |
| Arthrex | 28 | $1,906 |
| Amgen(2 entities) | 36 | $362 |
| Smith+Nephew | 2 | $137 |
| Zimmer Biomet | 3 | $112 |
| Pacira Pharmaceuticals Incorporated | 5 | $106 |
| Johnson & Johnson(2 entities) | 3 | $81 |
| Kerecis Limited | 2 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $51 |
| Bioventus LLC | 1 | $51 |
| Stryker | 1 | $40 |
| Vertex | 2 | $36 |
| Baudax Bio Inc. | 1 | $24 |
| Philips North America LLC | 1 | $21 |
| Total Joint Orthopedics, Inc. | 1 | $21 |
| Heraeus Medical, LLC. | 1 | $20 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Pfizer | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Medela LLC | 1 | $10 |
| Sonex Health, Inc. | 1 | $8 |
How this compares
$7,646 in reported general payments places this provider in the 65th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 91 | $1,746 |
| Meloxicam | 334 | $1,013 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $474 |
| Tramadol Hcl | 116 | $400 |
| Methylprednisolone | 58 | $379 |
| Gabapentin | 97 | $324 |
| Ibuprofen | 29 | $250 |
| Diclofenac Sodium | 11 | $181 |
| Pregabalin | 15 | $135 |
| Prednisone | 86 | $114 |
| Cyclobenzaprine Hcl | 25 | $78 |
| Methocarbamol | 19 | $69 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Flowood
- Steven HendrixFlowood$15K
- Michael DulskeFlowood$10K
- Matthew GravesJackson$1.2M
- George van OstenTupelo$322K
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jamey BurrowJackson$130K
- Jeff AlmandJackson$109K
- Spencer MontgomeryJackson$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.